Research from the Blood Cancer Alliance reveals a significant disparity in access to new blood cancer treatments on the NHS.

Experts explain the difference between what it means to experience cancer remission versus being cured of the disease.

Japan-based Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeting therapy developed by Ionis ...

This cancer-patient dad of three young kids is grateful for a "sci-fi" blood treatment advanced by Vanderbilt and oncologist Dr. Olalekan Oluwole.

EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained ...

For years, HealthTree has been a trusted online resource for blood cancer patients, offering tools to help them navigate their diagnosis and treatment. Now, with the launch of the app, these ...

An experimental medicine from Protagonist Therapeutics stabilized red blood cells and improved symptoms in patients with a ...

The Leukemia & Lymphoma Society (LLS) has launched a new docuseries to inform blood cancer patients, caregivers, healthcare ...

Experts told The Post that while colorectal cancer is highly treatable when caught early, it’s often diagnosed at later ...

Scientists at Karolinska Institutet and Karolinska University Hospital have discovered specific proteins in the blood that ...

HealthTree App Offers Patient Support, Education, and Research Participation in One Seamless Platform ...